Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LNTH compared with BBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
LNTH
Lantheus Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
BBIO
BridgeBio Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LNTH
Lantheus Holdings, Inc.
vs
BBIO
BridgeBio Pharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BBIO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LNTH
11
ACIU
AC Immune
supplier
—
Jubilant HollisterStier
unlisted
supplier
—
POINT Biopharma Global
unlisted
supplier
—
Meilleur
unlisted
supplier
7 more · LNTH chain
›
Shared
0
No shared counterparties.
Only BBIO
8
NVS
Novartis
supplier
—
Stanford
unlisted
supplier
—
Alexion
unlisted
customer
—
Alexion Pharmaceuticals
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
customer
4 more · BBIO chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LNTH, solid
BBIO, dashed
LNTH
Lantheus Holdings, Inc.
Change
100.44
▲
+0.12%
· post 100.43
Mkt cap
$6.6B
Revenue
$388M
Q2 FY26
Revenue
$1.5B
FY24
BBIO
BridgeBio Pharma, Inc.
Change
74.93
▲
+5.93%
· post 74.74
Closed
Oct 30 '26
Mkt cap
$14.6B
Revenue
$353M
Q3 FY26
Revenue
$502M
FY25
vs
Compare
Closed
Oct 30 '26
LNTH
Lantheus Holdings, Inc.
vs
BBIO
BridgeBio Pharma, Inc.
100.44
▲
+0.12%
post 100.43
Price
74.93
▲
+5.93%
post 74.74
$6.6B
Mkt cap
$14.6B
Q2 FY26
$388M
Revenue
$353M
Q3 FY26
FY24
$1.5B
Revenue
$502M
FY25
Change
Change
LNTH
100.44
▲
+0.12%
vs
BBIO
74.93
▲
+5.93%
Closed
Oct 30 '26